BDBM50099784 4-{[1-(4-Carbamoyl-2-{2-[(9,10-dioxo-9,10-dihydro-phenanthrene-2-carbonyl)-amino]-acetylamino}-butyryl)-pyrrolidine-2-carbonyl]-amino}-4-(carboxymethyl-carbamoyl)-butyric acid::CHEMBL51489

SMILES NC(=O)CCC(NC(=O)CNC(=O)c1ccc-2c(c1)C(=O)C(=O)c1ccccc-21)C(=O)N1CCCC1C(=O)NC(CCC(O)=O)C(=O)NCC(O)=O

InChI Key InChIKey=GSUNVTRRYGIXEF-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50099784   

TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099784(4-{[1-(4-Carbamoyl-2-{2-[(9,10-dioxo-9,10-dihydro-...)
Affinity DataIC50:  700nMAssay Description:In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed